OOIR: Observatory of International Research

Papers

(The H4-Index of Arthritis Care & Research is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Baseline Dual‐Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate‐Lowering Therapy	163
Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double‐Blind, Placebo‐Controlled Trial	112
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	109
Virtually Speaking: The Impact of a Nationwide Synchronous and Asynchronous Learning Forum	96
Pregnancy Outcomes from a Multidisciplinary Obstetric‐Medicine/Rheumatology Clinic in the United States: A Five‐Year Retrospective Analysis	86
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	80
On Mentoring	75
Accuracy of Diagnostic Codes and Algorithms Used to Identify Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in Administrative Claims and Electronic Health Records: Systematic Review and Meta‐A	74
Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis	65
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An ARChiVe Registry Cohort Study	62
Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life?	55
Association of Changes in Hand Pain With BMI, Employment, and Mental Well‐Being Over Four Years in Patients With Hand Osteoarthritis	50
Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs	48
Issue Information	46
Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis	44
Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease	44
Clinically Relevant Subgroups Among Athletes Who Have Ruptured Their Anterior Cruciate Ligaments: A Delaware‐Oslo Cohort Study	43
Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group	42
Physician Views and Attitudes Regarding Tobacco‐Cessation Strategies for Patients with Rheumatoid Arthritis	42
Using Data‐Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate‐Lowering Therapy	39
Associations of Sleep and Shift Work With Osteoarthritis Risk	37
Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring	37
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study	36
Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controll	34
Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study	34

Opioid Use Among Medicare Beneficiaries With Knee Osteoarthritis: Prevalence and Correlates of Chronic Use	34
Pregnancy Outcomes of Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review	33
Rheumatoid arthritis disease activity and hospitalized infection in a large US registry: comment on the article by Yun et al	32
Association of Systemic Sclerosis With Incident Clinically Evident Heart Failure	32
Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach	30